Europe Artificial Tears Market to Grow at a CAGR of 5.9% to reach US$ 816.9 Mn Million from 2021 to 2028

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Europe Artificial Tears Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Europe Artificial Tears Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing prevalence of dry eye is expected to drive the artificial tears market

5.2 Market Opportunities

5.2.1 Launch of the novel product has helped the company retain its position in the eye drop industry, such strategic events are likely to offer lucrative opportunity for the artificial tears market during the forecast period.

5.3 Future Trends

5.3.1 Change in lifestyle would eventually damage the eye health, generating a greater demand for artificial tear drops during the forecast period.

5.4 Impact of Drivers and Restraints

6. Europe Artificial Tears Market Regional Analysis

6.1 Europe Artificial Tears Market Overview

6.2 Europe Artificial Tears Market Revenue 2019-2028 (US$ Million)

6.3 Europe Artificial Tears Market Forecast Analysis

7. Europe Artificial Tears Market Analysis – by Type

7.1 Cellulose Derived Tears

7.1.1 Overview
7.1.2 Cellulose Derived Tears: Europe Artificial Tears Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Glycerin Derived Tears

7.2.1 Overview
7.2.2 Glycerin Derived Tears: Europe Artificial Tears Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Oil-based Emulsion Tears

7.3.1 Overview
7.3.2 Oil-based Emulsion Tears: Europe Artificial Tears Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Polythylene Glycol Based Tears

7.4.1 Overview
7.4.2 Polythylene Glycol Based Tears: Europe Artificial Tears Market – Revenue and Forecast to 2031 (US$ Million)

7.5 Propylene Glycol Based Tears

7.5.1 Overview
7.5.2 Propylene Glycol Based Tears: Europe Artificial Tears Market – Revenue and Forecast to 2031 (US$ Million)

7.6 Sodium Hyaluronate Based Artificial Tears

7.6.1 Overview
7.6.2 Sodium Hyaluronate Based Artificial Tears: Europe Artificial Tears Market – Revenue and Forecast to 2031 (US$ Million)

8. Europe Artificial Tears Market Analysis – by Delivery Mode

8.1 Eye Drops

8.1.1 Overview
8.1.2 Eye Drops: Europe Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Ointments

8.2.1 Overview
8.2.2 Ointments: Europe Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

9. Europe Artificial Tears Market Analysis – by Application

9.1 Dry Eyes Treatment

9.1.1 Overview
9.1.2 Ointments: Europe Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Contact Lenses Moisture

9.2.1 Overview
9.2.2 Ointments: Europe Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

10. Europe Artificial Tears Market – Europe Analysis

10.1 Europe

10.1.1 Europe Artificial Tears Market Breakdown, by Key Country, 2022 and 2028 (%)
10.1.1.1 Europe Artificial Tears Market – Revenue and Forecast Analysis – by Country
10.1.1.1 UK: Europe Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 UK: Europe Artificial Tears Market Breakdown, by Type
10.1.1.1.2 UK: Europe Artificial Tears Market Breakdown, by Delivery Mode
10.1.1.1.3 UK: Europe Artificial Tears Market Breakdown, by Application

10.1.1.2 Germany: Europe Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Germany: Europe Artificial Tears Market Breakdown, by Type
10.1.1.2.2 Germany: Europe Artificial Tears Market Breakdown, by Delivery Mode
10.1.1.2.3 Germany: Europe Artificial Tears Market Breakdown, by Application

10.1.1.3 France: Europe Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 France: Europe Artificial Tears Market Breakdown, by Type
10.1.1.3.2 France: Europe Artificial Tears Market Breakdown, by Delivery Mode
10.1.1.3.3 France: Europe Artificial Tears Market Breakdown, by Application

10.1.1.4 Russia: Europe Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Russia: Europe Artificial Tears Market Breakdown, by Type
10.1.1.4.2 Russia: Europe Artificial Tears Market Breakdown, by Delivery Mode
10.1.1.4.3 Russia: Europe Artificial Tears Market Breakdown, by Application

10.1.1.5 Italy: Europe Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1 Italy: Europe Artificial Tears Market Breakdown, by Type
10.1.1.5.2 Italy: Europe Artificial Tears Market Breakdown, by Delivery Mode
10.1.1.5.3 Italy: Europe Artificial Tears Market Breakdown, by Application

10.1.1.6 Rest of Europe: Europe Artificial Tears Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1 Rest of Europe: Europe Artificial Tears Market Breakdown, by Type
10.1.1.6.2 Rest of Europe: Europe Artificial Tears Market Breakdown, by Delivery Mode
10.1.1.6.3 Rest of Europe: Europe Artificial Tears Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Europe Artificial Tears Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Johnson and Johnson Services, Inc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Alcon Inc.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 OASIS Medical

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 AbbVie Inc.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Bayer AG

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Prestige Consumer Healthcare Inc.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Santen Pharmaceutical Co., Ltd.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Bausch Health Companies Inc.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights